EUVIMEDEUVIMED entdecken
Crossref

P-006 Targeting oxidative stress in male infertility: optimization and validation of a diagnostic tool

A Moazamian, S Somkuti, R J Aitken, J Drevet, P Gharagozloo

Human Reproduction · 01.06.2025 · 40 (Supplement_1)

DOI: 10.1093/humrep/deaf097.315 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Human Reproduction, online erschienen am 23.06.2025. Verfasst von A Moazamian und 4 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Study question Can an optimized assay for sperm DNA oxidation provide reproducible and clinically meaningful measurements to improve diagnostic evaluation of male infertility in ART? Summary answer The optimized sperm DNA oxidation assay demonstrated high reproducibility, broad clinical applicability, and sensitivity to transient damage, highlighting its potential to enhance male infertility diagnostics. What is known already Oxidative stress induces sperm DNA damage, contributing to adverse reproductive outcomes. The DNA oxidation marker 8-hydroxy-2'-deoxyguanosine (8-OHdG) is a key driver of de novo mutations post-fertilization. Current assays for measuring oxidative damage impacting sperm lack reliability, standardization, and clinical applicability, often yielding inconsistent results. A robust, reproducible method to accurately detect DNA oxidation events is urgently needed to elucidate the causes of male infertility and enhance clinical decision-making for improved reproductive outcomes. Study design, size, duration Preliminary validation and optimization were conducted over three years using semen samples from volunteers and IVF patients. Preclinical studies involved in-vitro protocol adjustments to support clinical implementation. Observational evaluations of 118 clinical samples were performed over two years. A testicular hyperthermia model in four healthy volunteers assessed the assay’s sensitivity to transient DNA oxidation and recovery dynamics over a nine-week period. Participants/materials, setting, methods Semen samples from volunteers and IVF patients were collected according to WHO 2021 guidelines. Initial assay workup was conducted onsite, with flow cytometric analysis performed at a university core facility. Computer-assisted semen analysis (CASA) supported evaluations of sperm parameters. A testicular hyperthermia model (43 °C for 30 minutes over five days) in four volunteers assessed sperm concentration, motility, and DNA oxidation, with measurements taken before and up to nine weeks post-exposure. Main results and the role of chance The assay underwent rigorous preclinical validation, optimized through in-vitro experiments to address time and temperature variations, artificial oxidation, and freeze-thaw cycles for practical implementation. Minimal intra-individual variability (∼5–6%) was observed over 13–18 months in two volunteers, confirming its reproducibility. Clinical evaluations of 118 samples across two years (Year 1: n = 69; Year 2: n = 49) revealed oxidation levels ranging from ∼8% to ∼91%, with stable annual mean values (∼45–56%). This broad range enabled categorization of patients into low, moderate, and high oxidation groups. Results aligned with previously published immune-detection methods for 8-OHdG, validating the assay despite differences in protocols and populations. A controlled testicular hyperthermia model demonstrated the assay’s ability to detect transient oxidative spikes from lifestyle-induced stress while distinguishing these from an individual’s baseline redox state. These consistent findings across preclinical and clinical settings suggest the assay is a robust diagnostic tool for identifying patients at risk of oxidative sperm damage, with minimal influence from chance. Limitations, reasons for caution The study’s small sample size and limited geographic representation necessitate further validation in larger, more diverse populations. Reliance on flow cytometry expertise may restrict widespread implementation. While initial results are encouraging, randomized trials are essential to confirm definitive associations between the DNA oxidation biomarker and fertility outcomes. Wider implications of the findings Accurate detection of sperm DNA oxidation using the optimized assay could guide targeted interventions, such as personalized antioxidant therapy or lifestyle changes, for men at high risk. Its integration into routine fertility clinics may improve ART success rates, supporting couples in achieving healthier pregnancies and offspring. Trial registration number No

Zitieren

APA

Moazamian, A., Somkuti, S., Aitken, R. J., Drevet, J., & Gharagozloo, P. (2025). P-006 Targeting oxidative stress in male infertility: optimization and validation of a diagnostic tool. Human Reproduction, 40(Supplement_1). https://doi.org/10.1093/humrep/deaf097.315

Vancouver

Moazamian A, Somkuti S, Aitken RJ, Drevet J, Gharagozloo P. P-006 Targeting oxidative stress in male infertility: optimization and validation of a diagnostic tool. Human Reproduction. 2025;40(Supplement_1). doi:10.1093/humrep/deaf097.315

BibTeX
@article{Moazamian2025,
  author = {Moazamian, A and Somkuti, S and Aitken, R J and Drevet, J and Gharagozloo, P},
  title = {P-006 Targeting oxidative stress in male infertility: optimization and validation of a diagnostic tool},
  journal = {Human Reproduction},
  year = {2025},
  volume = {40},
  number = {Supplement_1},
  doi = {10.1093/humrep/deaf097.315}
}
Kostenlos starten →